Exploring Outcome Priorities and Real-Life Management of Chemotherapy-Induced Peripheral Neurotoxicity: A Survey of the Italian Association for the Study of Pain members

References

• Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470. doi:10.1016/j.pain.2014.09.020
   PubMed Web of Science ®Google Scholar
• Kishimoto S, Oshima N, Rinker M, et al. Identification of high-risk drugs related to chemotherapy- induced peripheral neuropathy in cancer therapy evaluation program-sponsored Phase I trials. Eur J Cancer. 2019;115:111–119. doi:10.1016/j.ejca.2019.04.023
   PubMed Web of Science ®Google Scholar
• Mezzanotte JN, Grimm M, Shinde NV, et al. Updates in the treatment of chemotherapy- induced peripheral neuropathy. Updates in the treatment of chemotherapy-induced peripheral neuropathy. Curr Treat Options in Oncol. 2022;23:29–42. doi:10.1007/s11864-021-00926-0
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325–3348. doi:10.1200/JCO.20.01399
   PubMed Web of Science ®Google Scholar
• Gewandter JS, Brell J, Cavaletti G, et al. Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations neurology. Neurology. 2018;91(9):403–413. doi:10.1212/WNL.0000000000006083
   PubMed Web of Science ®Google Scholar
• Evans SR, Rubin D, Follmann D, et al. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR). Clin Infect Dis. 2015;61(5):800–806. doi:10.1093/cid/civ495
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap)-A metadata- driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90–95. doi:10.1109/MCSE.2007.55
   Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing; 2014.
   Google Scholar
• D’ambrosio A, Amodio S, Mazzeo G. ConsRank: compute the median ranking(s) according to the Kemeny’s axiomatic approach; 2021. Available from: https://cran.r-project.org/web/packages/ConsRank/ConsRank.pdf. Accessed Sptember 19, 2023.
   Google Scholar
• Amodio S, Ambrosio A, Siciliano R. Accurate algorithms for identifying the median ranking when dealing with weak and partial rankings under the Kemeny axiomatic approach. Eur J Oper Res. 2016;249(2):667–676. doi:10.1016/j.ejor.2015.08.048
   Web of Science ®Google Scholar
• Abd-Elsayed A, Gyorfi M, Hughes M. Spinal cord stimulator for treating chemotherapy-induced peripheral neuropathy. Pain Med Case Rep. 2021;5:4.
   Google Scholar
• Kamdar MM, Mccall LW, Saba AM, et al. Improvement in neuropathic pain, proprioception, and gait stability after spinal cord stimulator implantation for chemotherapy-induced peripheral neuropathy. Pain Med Case Rep. 2021;5(6):6. doi:10.36076/pmcr.2021.5.291
   Google Scholar
• Emond EJ, Mason DW. A new rank correlation coefficient with application to the consensus ranking problem. J Multi-Criteria Decis Anal. 2002;11(1):17–28. doi:10.1002/mcda.313
   Google Scholar
• Williams DJ, Creech CB, Walter EB, et al. Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022;176(3):253–261. doi:10.1001/jamapediatrics.2021.5547
   PubMed Web of Science ®Google Scholar
• Tamburin S, Park SB, Schenone A, et al. Rehabilitation, exercise, and related non- pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. Crit Rev Oncol Hematol. 2022;171:103575. doi:10.1016/j.critrevonc.2021.103575
   PubMed Web of Science ®Google Scholar
• Chen G, Zhang YQ, Qadri YJ, et al. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018;100(6):1292–1311. doi:10.1016/j.neuron.2018.11.009
   PubMed Web of Science ®Google Scholar
• Zajączkowska R, Kocot-Kępska M, Leppert W, et al. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20(6):1451.
   PubMed Web of Science ®Google Scholar
• Naguib M, Xu JJ, Diaz P, et al. Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid Type 2 receptor system. Anesth Analg. 2012;114(5):1104–1120. doi:10.1213/ANE.0b013e31824b0191
   PubMed Web of Science ®Google Scholar
• Cristiano C, Avagliano C, Cuozzo M, et al. The beneficial effects of ultramicronized palmitoylethanolamide in the management of neuropathic pain and associated mood disorders induced by paclitaxel in mice. Biomolecules. 2022;12(8):1155. doi:10.3390/biom12081155
   PubMed Web of Science ®Google Scholar
• Mannelli LDC, Pacini A, Corti F, et al. Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity. PLoS One. 2015;10:128080.
   Web of Science ®Google Scholar
• Donvito G, Wilkerson JL, Damaj MI, et al. Palmitoylethanolamide reverses paclitaxel-induced allodynia in mice. J Pharmacol Exp Ther. 2016;359(2):310–318. doi:10.1124/jpet.116.236182
   PubMed Web of Science ®Google Scholar
• Truini A, Biasiotta A, Stefano GD, et al. Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy. CNS Neurol Disord Drug Targets. 2011;10(8):916–920. doi:10.2174/187152711799219307
   PubMed Web of Science ®Google Scholar
• Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–1319. doi:10.1016/j.annonc.2020.07.003
   PubMed Web of Science ®Google Scholar
• Dinicola S, Fuso A, Cucina A, et al. Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy. Eur Rev Med Pharmacol Sci. 2018;22(14):4739–4754. doi:10.26355/eurrev_201807_15534
   PubMed Web of Science ®Google Scholar
• Werida RH, Elshafiey RA, Ghoneim A, et al. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients. Support Care Cancer. 2022;30(9):7281–7292. doi:10.1007/s00520-022-07124-0
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: systematic review, meta-analysis and updated NeuPSIG recommendations. Lancet Neurol. 2015;14(2):162–173. doi:10.1016/S1474-4422(14)70251-0
   PubMed Web of Science ®Google Scholar
• Patel R, Dickenson AH. Mechanisms of the gabapentinoids and α 2 δ −1 calcium channel subunit in neuropathic pain. Pharmacol Res Perspect. 2016;4(2):e00205. doi:10.1002/prp2.205
   PubMed Web of Science ®Google Scholar
• Doan L. Voltage-gated calcium channels and pain. Reg Anesth Pain Manag. 2010;14:42–47. doi:10.1053/j.trap.2010.03.003
   Google Scholar
• Knoerl R, Smith EML, Barton DL, et al. Self-guided online cognitive behavioral strategies for chemotherapy-induced peripheral neuropathy: a multicenter, pilot, randomized, wait-list controlled trial. J Pain. 2018;19:382–394. doi:10.1016/j.jpain.2017.11.009
   PubMed Web of Science ®Google Scholar
• Knoerl R, Giobbie-Hurder A, Berfield J, et al. Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial. J Cancer Surviv Res Pract. 2022;16:882–891.
   PubMed Web of Science ®Google Scholar
• Simons LE, Elman I, Borsook D. Psychological processing in chronic pain: a neural systems approach. Neurosci Biobehav Rev. 2014;39:61–78. doi:10.1016/j.neubiorev.2013.12.006
   PubMed Web of Science ®Google Scholar
• Sturgeon J. Psychological therapies for the management of chronic pain. Psychol Res Behav Manag. 2014;115. doi:10.2147/PRBM.S44762
   PubMedGoogle Scholar
• Loprinzi C, Le-rademacher JG, Majithia N, et al. Scrambler therapy for chemotherapy neuropathy: a randomized Phase II pilot trial. Support Care Cancer. 2020;28:1183–1197. doi:10.1007/s00520-019-04881-3
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med. 1994;23:129–138.
   PubMedGoogle Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1–2):9–19. doi:10.1016/j.pain.2004.09.012
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36. doi:10.1016/j.pain.2004.12.010
   PubMed Web of Science ®Google Scholar
• Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain. 1975;1:277–299. doi:10.1016/0304-3959(75)90044-5
   PubMed Web of Science ®Google Scholar
• Melzack R, Raja S. The McGill pain questionnaire: from description to measurement. Anesthesiology. 2005;103:199–202. doi:10.1097/00000542-200507000-00028
   PubMed Web of Science ®Google Scholar
• Postma TJ, Aaronson NK, Heimans JJ, et al. The development of an EORTC Quality of Life Questionnaire to assess Chemotherapy-Induced Peripheral Neuropathy: the QLQ-CIPN20. Eur J Cancer Oxf Engl. 1990;41:1135–1139. doi:10.1016/j.ejca.2005.02.012
   Google Scholar
• Calhoun EA, Welshman EE, Chang CH, et al. Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer. 2003;13:741–748.
   PubMed Web of Science ®Google Scholar
• Li T, Park SB, Battaglini E, et al. Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use. Qual Life Res. 2022;31(11):3091–3107. doi:10.1007/s11136-022-03154-7
   PubMed Web of Science ®Google Scholar